Estrogel package

Notice: Product images are for illustration purposes only and may differ from the medication you receive. Packaging and appearance may vary depending on the country of origin, and generic medications may be supplied by different manufacturers. The medication, strength, and active ingredients will match your prescription. At the Canadian Pharmacy Store we prioritize your health and safety by working with licensed pharmacy partners to provide safe, high-quality medications.

Estrogel (Estradiol)

Estrogel

Estradiol

Sourced from Canada Source: Canada
Prescription Required
Select product strength & quantity:

Estrogel

Estradiol

Sourced from United Kingdom Source: United Kingdom
Prescription Required
Select product strength & quantity:
Select Strength & Quantity

Choose the strength, form, and package size that match your prescription.

Send Your Prescription

Upload your prescription online, request a transfer, or have your doctor fax us.

Pharmacist Review & Delivery

Reviewed by a licensed pharmacist and shipped to your U.S. address with tracking. Shipping details.

Description

Estrogel (estradiol) is an estrogen listed in our Women's health medications directory and prescribed for specified menopause-related symptoms and specified bone disorders (1.1) (2.1). administered via the transdermal route, Estrogel is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.

Estrogel is a medication containing the active pharmaceutical ingredient estradiol, classified pharmacologically as an estrogen (2.1). It is clinically indicated for the management of specified menopause-related symptoms and specified bone disorders as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).

Within the Women's health medications section of our catalogue, patients and prescribers frequently review Estrogel alongside related therapies such as Divigel (Estradiol), Estalis (Estradiol / Norethindrone), Estrace (Estradiol), and Imvexxy (Estradiol).

Official Indications and Usage

Estrogel is indicated for: minivelle® is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause Prevention of postmenopausal osteoporosis ​.

Limitations of use: When prescribing solely for the treatment of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis. (1.1)

Mechanism of Action and Pharmacology

Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen and is substantially more potent than its metabolites, estrone and estriol, at the receptor level. The primary source of estrogen in normally cycling adult women is the ovarian follicle, which secretes 70 to 500 mcg of estradiol daily, depending on the phase of the menstrual cycle. After menopause, most endogenous estrogen is produced by conversion of androstenedione, secreted by the adrenal cortex, to estrone in the peripheral tissues. (1.1)

What is Menopause?

Menopause marks the end of menstrual periods and can involve several symptoms. Hormonal and nonhormonal treatments have different purposes and risks. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Menopause condition guide for appointment questions and related therapies (2.1).

What is Osteoporosis?

Osteoporosis weakens bones and increases fracture risk. Treatment considers fracture history, bone measurements, and other health factors. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Osteoporosis condition guide for appointment questions and related therapies (2.1).

Ordering Estrogel from Canada for U.S. Delivery

U.S. patients can order Estrogel (Estradiol) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.

Step 1

Send Your Prescription

Step 2

Pharmacist Safety Check

  • Multi-point dosing and interaction review completed in under 1 business day.
  • Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
  • Verified under our Pharmacy Safety Standards.
Step 3

$14.99 USD Tracked Parcel

  • Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
  • Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
  • Review full shipping and delivery details.
Step 4

U.S. Street Delivery & Payment

  • Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
  • You see and approve the country of origin upfront before your card is charged.
  • Report any delayed or damaged parcel within 48 hours for prompt resolution.

Fact Table

Clinical Specification Details
Brand / Product Name Estrogel
Chemical / Generic Name Estradiol
Pharmacological Class Estrogen
Therapeutic Category Women's health medications
Same-Ingredient Catalogue Entries Divigel (Estradiol), Estalis (Estradiol / Norethindrone), Estrace (Estradiol), Imvexxy (Estradiol)
Molecular Weight 272.39 g/mol (2.1)
Legal Status Rx-Only (Prescription Required)
Regulatory Reference Authorities U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus
Routes of Administration Transdermal
Dosage Forms & Strengths Transdermal system: 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day. Transdermal system: 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day
Primary Indications Specified Menopause-Related Symptoms And Specified Bone Disorders
Pregnancy & Breastfeeding Consult Doctor / Prescriber before use
FDA UNII Identifier 4TI98Z838E
NLM RxNorm Concept ID (RxCUI) 241946, 242891, 242892, 248478
FDA Application License NDA203752
Official DailyMed SetID 6c5c47ab-28ee-11e1-bfc2-0800200c9a66
Catalogue Index Links Letter E Index · All Medications · All Categories

Directions

Dosage and Administration Overview

Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, consider addition of a progestogen to reduce the risk of endometrial cancer. Generally, a woman without a uterus, does not need to use a progestogen in addition to her estrogen therapy. In some cases, however, hysterectomized women who have a history of endometriosis may need a progestogen. Use estrogen-alone, or in combination with a progestogen, at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Reevaluate postmenopausal women periodically as clinically appropriate to determine if treatment is still necessary. (1.1)

Presentations and Strengths

Transdermal system: 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day. (1.1)

Administration Guidance

Apply Estrogel transdermally to clean, dry, intact, hairless skin on the body site recommended in the patient leaflet (1.1). Rotate application sites with each new patch or gel dose, press patches firmly in place for 10 to 30 seconds, wash hands after handling transdermal gels, and fold used patches in half (sticky sides together) for safe disposal.

Missed Dose Guidance

If you miss a scheduled dose of Estrogel, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).

Ingredients

Active Pharmaceutical Ingredient

The active ingredient in Estrogel is estradiol (2.1). Other catalogue entries containing estradiol include Divigel (Estradiol), Estalis (Estradiol / Norethindrone), Estrace (Estradiol), and Imvexxy (Estradiol).

Excipients and Formulation Carriers

Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).

Cautions and important safety information

Boxed Warning

Warning: endometrial cancer, cardiovascular disorders, probable dementia, and breast cancer Estrogen-Alone Therapy Endometrial Cancer There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens. Adding a progestogen to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer. Perform adequate diagnostic measures, including directed or random endometrial sampling when indicated, to rule out malignancy in postmenopausal women with undiagnosed persistent or recurring abnormal genital bleeding. (1.1)

Contraindications

Estrogel is contraindicated in women with any of the following conditions: Undiagnosed abnormal genital bleeding. Breast cancer or a history of breast cancer. Estrogen-dependent neoplasia. Active DVT, PE, or a history of these conditions. (1.1)

Key Clinical Precautions

Before starting or continuing Estrogel, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):

  • Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
  • Malignancy monitoring: Follow age-appropriate and treatment-specific screening recommendations discussed with your prescribing specialist.
  • Acute pancreatitis: Persistent, severe abdominal pain, sometimes radiating to the back and accompanied by vomiting, can indicate acute pancreatitis. Discontinue therapy and contact your clinician promptly if these symptoms develop.
  • Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
  • Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
  • Blood pressure elevation: Monitor blood pressure regularly during treatment and inform your clinician if sustained increases occur.

Pregnancy, Lactation, and Special Populations

Minivelle is not indicated for use in pregnancy. In the U.S. General population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. (1.1)

Interactions

Official Drug Interaction Overview

In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4). Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers of CYP3A4 such as St. John’s wort (Hypericum perforatum) preparations, phenobarbital, carbamazepine and rifampin may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile. Inhibitors of CYP3A4 such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, and grapefruit juice may increase plasma concentrations of estrogens and may result in adverse reactions. (1.1)

Important Interaction Categories

Concomitant use of Estrogel with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):

  • Strong CYP3A4 inhibitors and inducers (such as ketoconazole, itraconazole, clarithromycin, ritonavir, rifampin, carbamazepine, phenytoin, or St. John’s wort): Co-administration with strong CYP3A4 inhibitors can significantly increase plasma concentrations and side-effect risk, whereas CYP3A4 inducers can decrease systemic exposure and reduce efficacy.

Side effects

Like all medications, Estrogel can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):

  • Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
  • Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
  • Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
  • Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
  • Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
  • Insomnia or sleep disturbances: Taking morning doses earlier in the day (if consistent with your prescription) may reduce nighttime restlessness.

Clinical Trial and Postmarketing Adverse Reactions

The most common adverse reactions (greater than or equal to 5 percent) with minivelle are: headache, breast tenderness, back pain, pain in limb, nasopharyngitis, dyspepsia, nausea, sinusitis, and intermenstrual bleeding. There were no clinical trials conducted with minivelle. Minivelle is bioequivalent to Vivelle ®. (1.1)

When to Seek Immediate Medical Attention

Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).

Storage and handling

Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) Do not store unpouched. Apply immediately upon removal from the protective pouch. Used transdermal systems still contain active hormone. To discard, fold the sticky side of the transdermal system together, place it in a sturdy child-proof container, and place this container in the trash. Used transdermal systems should not be flushed in the toilet. (1.1)

Store Estrogel in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).

Frequently Asked Questions About Estrogel

What is Estrogel and what active ingredient does it contain?

Estrogel is an estrogen containing the active pharmaceutical ingredient estradiol. It is supplied for transdermal administration and requires a valid prescription where applicable.

How does Estrogel work in the body?

Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen and is substantially more potent than its metabolites, estrone and estriol, at the receptor level. The primary source of estrogen in normally cycling adult women is the ovarian follicle, which secretes 70 to 500 mcg of estradiol daily, depending on the phase of the menstrual cycle.

What conditions is Estrogel prescribed to treat?

Estrogel is primarily indicated for specified menopause-related symptoms and specified bone disorders. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.

How should I take or use Estrogel?

Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Estrogel is administered via the transdermal route. Apply it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.

What are the most common side effects of Estrogel?

Commonly reported side effects of Estrogel include feeling sick, loose stools, constipation, headache, dizziness, and difficulty sleeping. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.

What medications or substances can interact with Estrogel?

Important interaction categories for Estrogel include medicines that strongly affect CYP3A enzymes. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.

Can Estrogel be used during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Estrogel to weigh the clinical benefits and potential risks.

Do I need a prescription to buy Estrogel online from Canada?

Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Estrogel (Estradiol) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).

Does Estrogel have a generic equivalent (Estradiol) at a Canada pharmacy?

Currently, Estrogel (Estradiol) is dispensed in our catalogue as a brand-name formulation. Check our Estradiol active ingredient hub for updates as licensed generic presentations become available.

How is Estrogel shipped to U.S. residents, and how much does shipping cost?

Estrogel ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.

How can I send or transfer my Estrogel prescription, or ask about an unlisted strength?

You can upload a clear photo or PDF of your Estrogel prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.

References & Official Sources

Clinical, pharmacological, and safety facts for Estrogel (Estradiol) are compiled directly from official regulatory prescribing labels and primary biomedical databases:

  1. (1.1) Minivelle. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
  2. (2.1) MedlinePlus Medical Encyclopedia: Menopause. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  3. (3.1) MedlinePlus Medical Encyclopedia: Osteoporosis. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
  4. (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).

Related Condition Guides

Related Guides

Call 1-888-868-1920Help